« Previous
Next »
Seminars in Nephrology
Volume 28, Issue 3
, Pages 245-251
, May 2008
Vasopressin Receptor Mutations in Nephrogenic Diabetes Insipidus
References
- . The G-protein-coupled receptors in the human genome form five main families (Phylogenetic analysis, paralogon groups, and fingerprints). Mol Pharmacol. 2003;63:1256–1272
- . The evolutionarily triumphant G-protein-coupled receptor. Mol Pharmacol. 2003;63:1202–1205
- Crystal structure of the human beta2 adrenergic G-protein-coupled receptor. Nature. 2007;450:383–387
- High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science. 2007;318:1258–1265
- GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function. Science. 2007;318:1266–1273
- . Aquaporins in the kidney: from molecules to medicine. Physiol Rev. 2002;82:205–244
- . Localized effects of cAMP mediated by distinct routes of protein kinase A. Physiol Rev. 2004;84:137–167
- . AKAP signaling complexes: getting to the heart of the matter. Trends Mol Med. 2006;12:317–323
- . Discrete microdomains with high concentration of cAMP in stimulated rat neonatal cardiac myocytes. Science. 2002;295:1711–1715
- Identification of a novel A-kinase anchoring protein 18 isoform and evidence for its role in the vasopressin-induced aquaporin-2 shuttle in renal principal cells. J Biol Chem. 2004;279:26654–26665
- . Mutation of an A-kinase-anchoring protein causes long-QT syndrome. Proc Natl Acad Sci U S A. 2007;104:20990–20995
- . Urea-selective concentrating defect in transgenic mice lacking urea transporter UT-B. J Biol Chem. 2002;277:10633–10637
- . Urea and urine concentrating ability: new insights from studies in mice. Am J Physiol Renal Physiol. 2005;288:F881–F896
- . Vasopressin-V2 receptor stimulation reduces sodium excretion in healthy humans. J Am Soc Nephrol. 2005;16:1920–1928
- . Minireview: regulation of epithelial Na+ channel trafficking. Endocrinology. 2005;146:5079–5085
- . Molecular biology of hereditary diabetes insipidus. J Am Soc Nephrol. 2005;16:2836–2846
- Report of 33 novel AVPR2 mutations and analysis of 117 families with X-linked nephrogenic diabetes insipidus. J Am Soc Nephrol. 2000;11:1044–1054
- Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants. J Clin Invest. 2000;105:887–895
- . G protein-coupled receptor trafficking in health and disease: lessons learned to prepare for therapeutic mutant rescue in vivo. Pharmacol Rev. 2007;59:225–250
- . A cure for traffic jams: small molecule chaperones in the endoplasmic reticulum. Traffic. 2004;5:815–820
- . The biological impact of mass-spectrometry-based proteomics. Nature. 2007;450:991–1000
- Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis. Cell. 2006;127:803–815
- . Therapeutic approaches to protein-misfolding diseases. Nature. 2003;426:905–909
- Pharmacologic chaperones as a potential treatment for X-linked nephrogenic diabetes insipidus. J Am Soc Nephrol. 2006;17:232–243
- . Functional rescue of the constitutively internalized V2 vasopressin receptor mutant R137H by the pharmacological chaperone action of SR49059. Mol Endocrinol. 2004;18:2074–2084
- . Severe bladder dysfunction in a family with ADH receptor gene mutation responsible for X-linked nephrogenic diabetes insipidus. Nephrol Dial Transplant. 2004;19:2928–2929
- . Bladder function impairment in aquaporin-2 defective nephrogenic diabetes insipidus. Nephrol Dial Transplant. 2004;19:608–613
- . Mouse model of inducible nephrogenic diabetes insipidus produced by floxed aquaporin-2 gene deletion. Am J Physiol Renal Physiol. 2006;291:F465–F472
- . Crystal structure of the catalytic domains of adenylyl cyclase in a complex with Gsalpha.GTPgammaS. Science. 1997;278:1907–1916
- The binding site of neuropeptide vasopressin V1a receptor (Evidence for a major localization within transmembrane regions). J Biol Chem. 1995;270:25771–25777
This study was supported by the Canadian Institutes of Health Research, and by the Kidney Foundation of Canada. Dr. Bichet holds a Canada Research Chair in Genetics of Renal Diseases.
PII: S0270-9295(08)00048-X
doi: 10.1016/j.semnephrol.2008.03.005
© 2008 Elsevier Inc. All rights reserved.
« Previous
Next »
Seminars in Nephrology
Volume 28, Issue 3
, Pages 245-251
, May 2008
